Startups
SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.
Summary
59
Industry
Total funding Amount
$53M
Fundraising History
-
Oct 01 '20 Series A$53M
Investors
-
Ysios CapitalSeries A